Diethylamino hydroxybenzoyl hexyl benzoate

DB11269ApprovedSmall molecule

Diethylamino hydroxybenzoyl hexyl benzoate is a UV filter with high absorption in the UV-A range. Minimizing the overexposure of human skin to ultraviolet radiation that may lead to acute and... Diethylamino hydroxybenzoyl hexyl benzoate was approved in Europe in 2005, and is also marketed in the U.S., South America, Mexico, Japan and Taiwan.

Mechanism: Diethylamino hydroxybenzoyl hexyl benzoate absorbs in the UV-A range with the peak at 354 nm.
Curator reviewed · 1 reference
Primary indication: Indicated for use as a sunscreen agent.Curator reviewed · 1 structured indication
Formula / weight: C₂₄H₃₁NO₄ · 397.515 g/mol (avg)

Resolves to

Compound

UNIIANQ870JD20CAS302776-68-7ChEBI136006

Clinical / RWD

RxNorm1426392

Structure

InChIKeyFDATWRLUYRHCJE-UHFFFAOYSA-NSMILESCCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(C=C1O)N(CC)CC

What you can answer from here — as of April 02, 2025

1Structured indicationCondition, population, route and combination as fields, not prose

32Marketed productsAcross 1 country and 18 labellers

5+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Diethylamino hydroxybenzoyl hexyl benzoate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account